Gates Scholar wins NC3R prize

  • January 30, 2009

Congratulations to Gates Scholar Tom Johnson (2006) (pictured below left) and his mentor Dr Keith Martin (pictured below right). The pair have been awarded the prestigious NC3R prize for their paper on a new model that can be used to investigate stem cell therapy for retinal disease, which will replace the use of animals in this crucial field. 

Tom JohnsonDr Keith Martin

 

aa

Tom is currently completing his PhD at the National Institute of Health in Bethesda, MD, USA in collaboration with the University of Cambridge Centre for Brain Repair.

For further information on Tom’s prize-winning paper and an abstract of it, please see:

http://www.nc3rs.org.uk/news.asp?id=1010

Latest News

Celebrating agricultural innovation in Africa

A foundation started by a Gates Cambridge Scholar is leading a Cambridge Festival event in March to celebrate agricultural innovation in Africa where a new project on food security will be launched. The Agri-Innovation & Impact Project (AGRIIP) will be launched at the Roots of Resilience event on 27th March. It is designed to empower […]

What makes Earth tick

It was during his master’s that Alex Myhill [2022] was introduced to Earth Science and realised just how much we don’t understand about the Earth. He wanted to explore further and his PhD seeks to understand the dynamics that make the Earth tick. He is developing new techniques for the efficient computation of whole Earth […]

25th anniversary panel to speak at Cambridge Festival

Five Scholars will speak about their ideas that could change the world at this year’s Cambridge Festival as part of the ongoing celebrations for Gates Cambridge’s 25th anniversary. The Festival programme has been published today and includes the Gates Cambridge event – Ideas that could change the world – hosted by international journalist Catherine Galloway […]

Study shows need for repeated vaccines for immunocompromised people

Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine has generated the production of antibodies, according to new research from the University of Cambridge led by a Gates Cambridge Scholar. The findings, published today in Science Advances, suggest that such individuals will need regular vaccine […]